Cabozantinib S-malate in Treating Patients With Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by Surgery

Clinical trial NCT02302833 · COMPLETED

Trial details

NCT number: NCT02302833
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Paraganglioma Metastatic Adrenal Gland Pheochromocytoma Metastatic Paraganglioma Regional Adrenal Gland Pheochromocytoma Unresectable Adrenal Gland Pheochromocytoma Unresectable Paraganglioma

Start date: 2015-02-17
Primary completion: 2024-11-12
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.